• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 25-NSE filed by Mountain Crest Acquisition Corp. II

    10/28/21 4:10:53 PM ET
    $MCAD
    Finance
    Get the next $MCAD alert in real time by email
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    UNITED STATES
    OMB APPROVAL
    OMB Number: 3235-0080
    Expires: March 31, 2018
    Estimated average burden
    hours per response: 1.7
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 25
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
    UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    Commission File Number 333-251557
    Issuer: Mountain Crest Acquisition Corp II
    Exchange: Nasdaq Stock Market LLC
    (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
    Address: 311 West 43rd Street
    12th Floor
    New York NEW YORK 10036
    Telephone number: (646) 493-6558
    (Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)
    rights, units
    (Description of class of securities)
    Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
    17 CFR 240.12d2-2(a)(1)
    17 CFR 240.12d2-2(a)(2)
    17 CFR 240.12d2-2(a)(3)
    17 CFR 240.12d2-2(a)(4)
    Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1
    Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
    Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
    2021-10-28 By Tara Petta Director
    Date Name Title
    1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $MCAD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MCAD

    DatePrice TargetRatingAnalyst
    7/29/2021$19.00Buy
    Lake Street
    More analyst ratings

    $MCAD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3: New insider Heinen Mark claimed ownership of 6,667 shares

      3 - Better Therapeutics, Inc. (0001832415) (Issuer)

      11/1/21 8:35:22 PM ET
      $MCAD
      Finance
    • SEC Form 4: Perry David P bought $2,512,432 worth of shares (251,536 units at $9.99) and was granted 10,578,501 shares

      4 - Better Therapeutics, Inc. (0001832415) (Issuer)

      11/1/21 8:55:45 PM ET
      $MCAD
      Finance
    • SEC Form 3: New insider Parker Geoffrey M. claimed ownership of 33,333 shares

      3 - Better Therapeutics, Inc. (0001832415) (Issuer)

      11/1/21 8:30:59 PM ET
      $MCAD
      Finance

    $MCAD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Better Therapeutics Closes Business Combination and Debuts on Nasdaq

      Trading to commence on Nasdaq on Oct. 29, 2021, under the ticker symbol BTTX Better Therapeutics, Inc., a prescription digital therapeutics (PDT) company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced the completion of its business combination with Mountain Crest Acquisition Corp II (NASDAQ:MCAD, "Mountain Crest II"))), a publicly traded special purpose acquisition corporation or SPAC. The resulting combined company will commence trading its shares on Nasdaq under the ticker symbol "BTTX" on October 29, 2021. The shareholders of Mountain Crest Acquisition Corp II approved the transaction at a special meeting held on October

      10/29/21 8:00:00 AM ET
      $MCAD
      Finance
    • Mountain Crest Acquisition Corp. II Stockholders Approve Business Combination with Better Therapeutics Inc.

      NEW YORK, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. II (NASDAQ:MCAD) (the "Company"), a publicly traded special purpose acquisition company, announced today that in a special meeting of stockholders on October 27, 2021, its stockholders voted to approve its proposed business combination (the "business combination") with Better Therapeutics Inc. ("Better Therapeutics"), a company engaged in developing a novel form of cognitive behavioral therapy to address the root causes of cardiometabolic diseases. The business combination is expected to close on October 28, 2021, subject to the satisfaction of certain customary closing conditions. As part of the consummation o

      10/27/21 4:44:29 PM ET
      $MCAD
      Finance
    • Mountain Crest Acquisition Corp. II and Better Therapeutics, Inc. Announce Registration Statement Effectiveness and Scheduled Special Meeting to Approve Business Combination on October 27, 2021

      NEW YORK and SAN FRANCISCO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. II (NASDAQ:MCAD, "Mountain Crest II"))), a publicly-traded special purpose acquisition company and Better Therapeutics, Inc. ("Better Therapeutics"), a prescription digital therapeutics (PDT) company developing cognitive behavioral therapy to address root causes of cardiometabolic diseases, today announced that MCAD's registration statement on Form S-4 (File No. 333-255493) relating to the previously announced merger of MCAD and Better Therapeutics has been declared effective by the U.S. Securities and Exchange Commission as of October 12, 2021. MCAD also announced that it will hold its special m

      10/12/21 8:00:04 PM ET
      $MCAD
      Finance

    $MCAD
    SEC Filings

    See more
    • Mountain Crest Acquisition Corp. II filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Amendments to the Registrant’s Code of Ethics, or Waiver of a Provision of the Code of Ethics, Change in Shell Company Status

      8-K - Better Therapeutics, Inc. (0001832415) (Filer)

      11/3/21 5:26:13 PM ET
      $MCAD
      Finance
    • SEC Form 25-NSE filed by Mountain Crest Acquisition Corp. II

      25-NSE - Mountain Crest Acquisition Corp II (0001832415) (Subject)

      10/28/21 4:10:53 PM ET
      $MCAD
      Finance
    • SEC Form 425 filed by Mountain Crest Acquisition Corp. II

      425 - Mountain Crest Acquisition Corp II (0001832415) (Subject)

      10/27/21 5:21:36 PM ET
      $MCAD
      Finance

    $MCAD
    Leadership Updates

    Live Leadership Updates

    See more
    • Better Therapeutics Appoints Dr. Risa Lavizzo-Mourey to its Board of Directors

      Better Therapeutics, Inc., a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced the appointment of Dr. Risa Lavizzo-Mourey to its board of directors; she will also serve as Compensation Committee chair. "Dr. Lavizzo-Mourey brings critical insights into health policy, as well as her background as a primary care physician at a critical juncture for Better Therapeutics," said David Perry, co-founder and chairman of Better Therapeutics. "Her experience and counsel will help us establish our prescription digital therapeutics as the new standard of care for people with cardiometabolic diseases.

      4/20/21 8:00:00 AM ET
      $MRK
      $GE
      $INTC
      $MCAD
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Consumer Electronics/Appliances
      Technology

    $MCAD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Lake Street initiated coverage on Mountain Crest Acquisition Corp. II with a new price target

      Lake Street initiated coverage of Mountain Crest Acquisition Corp. II with a rating of Buy and set a new price target of $19.00

      7/29/21 9:53:58 AM ET
      $MCAD
      Finance

    $MCAD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D filed by Mountain Crest Acquisition Corp. II

      SC 13D - Better Therapeutics, Inc. (0001832415) (Subject)

      11/8/21 5:28:53 PM ET
      $MCAD
      Finance
    • SEC Form SC 13D filed by Mountain Crest Acquisition Corp. II

      SC 13D - Better Therapeutics, Inc. (0001832415) (Subject)

      11/8/21 5:26:04 PM ET
      $MCAD
      Finance
    • SEC Form SC 13G filed by Mountain Crest Acquisition Corp. II

      SC 13G - Better Therapeutics, Inc. (0001832415) (Subject)

      11/8/21 1:11:00 PM ET
      $MCAD
      Finance